Australia - English - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - etifenin, quantity: 20 mg; stannous chloride, quantity: 0.42 mg - injection, powder for - excipient ingredients: - indications as at 25 september 1996: technetium (99mtc) etifenin may be used as a hepatobiliary imaging pharmaceutical.

Australia - English - Department of Health (Therapeutic Goods Administration)

stannous chloride; etifenin; tin(ii)chloride -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo pharma b.v. - ibuprofen 200 mg - film-coated tablet - 200 mg - ibuprofen 200 mg - ibuprofen

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo pharma b.v. - ibuprofen 400 mg - film-coated tablet - 400 mg - ibuprofen 400 mg - ibuprofen

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo pharma b.v. - ibuprofen 200 mg - film-coated tablet - ibuprofen

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo pharma b.v. - ibuprofen 400 mg - film-coated tablet - ibuprofen

Kenya - English - Pharmacy and Poisons Board

tablets (india) limited. no 72 marshalls road chennai 600008 - co-trimoxazole tablets - tablet - trimethoprim bp 80 mg sulphamethoxazole bp 400 mg - antibacterials for systemic use: combinations of

Kenya - English - Pharmacy and Poisons Board

til healthcare ltd no 72 marshalls road chennai 600008 - co-trimoxazole oral suspension - oral suspension - trimethoprim bp 40 mg, sulphamethoxazole bp 200… - antibacterials for systemic use: combinations of

Australia - English - Department of Health (Therapeutic Goods Administration)

sigma company limited - iron polymaltose, quantity: 318 mg (equivalent: iron, qty 100 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 8 april 2002: for the treatment of iron deficiency anaemia in the following circumstances: * when oral therapy is contraindicated. * when enteric absorption of iron is defective. * when patient non-compliance or persistent gastrointestinal intolerance makes oral therapy impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - nintedanib esilate, quantity: 180.6 mg (equivalent: nintedanib, qty 150 mg) - capsule, soft - excipient ingredients: iron oxide red; titanium dioxide; hard fat; lecithin; gelatin; glycerol; iron oxide yellow; medium chain triglycerides; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - ofev is indicated in combination with docetaxel for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (nsclc) of adenocarcinoma tumour histology after failure of first line chemotherapy.,ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf).,ofev is also indicated for the treatment of other chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype.,ofev is indicated for slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (ssc-ild).